| Product NDC: | 55111-222 |
| Proprietary Name: | Lamotrigine |
| Non Proprietary Name: | Lamotrigine |
| Active Ingredient(s): | 150 mg/1 & nbsp; Lamotrigine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55111-222 |
| Labeler Name: | Dr.Reddy's Laboratories Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076708 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090129 |
| Package NDC: | 55111-222-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (55111-222-01) |
| NDC Code | 55111-222-01 |
| Proprietary Name | Lamotrigine |
| Package Description | 100 TABLET in 1 BOTTLE (55111-222-01) |
| Product NDC | 55111-222 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Lamotrigine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090129 |
| Marketing Category Name | ANDA |
| Labeler Name | Dr.Reddy's Laboratories Limited |
| Substance Name | LAMOTRIGINE |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |